DOJ to analyze Eargo’s insurance coverage reimbursement claims

Sensible listening to firm Eargo is the goal of a felony investigation by the U.S. Division of Justice (DOJ), the corporate mentioned in a Securities and Alternate Fee (SEC) submitting Wednesday.

The DOJ is trying into Eargo’s insurance coverage reimbursement claims that it submits on behalf of its prospects once they buy the corporate’s related listening to aids.

The probe is a part of an “ongoing claims audit” from Eargo’s largest third-party payer accomplice, the corporate mentioned. As of September 21, the DOJ is the principal contact for the audit.

Eargo mentioned it’s cooperating with the investigation and is working with the federal government to validate its reimbursement claims submission course of to keep away from future points.

Because of the investigation, Eargo shall be withdrawing its monetary steerage for the fiscal 12 months ending December 31.


Eargo sells related listening to gadgets on to customers. Its gadgets sync to the Eargo app, the place customers can alter their listening to preferences primarily based on bass and treble ranges, or by the setting.

The corporate’s inventory (EAR) plunged yesterday after the SEC doc was filed, falling by $14.77 as of Thursday morning under its earlier closing worth. The corporate is at present buying and selling for $6.90 a share.

The investigation additionally has market analysts altering their tune on Eargo. Wells Fargo Securities analyst Lawrence Biegelsen lowered Eargo’s beneficial worth goal from $52 to $10 and JPMorgan analyst Robbie Marcus lowered his suggestions from $44 to $11.


Final 12 months was an enormous 12 months for Eargo. It raised $71 million final July to develop the commercialization of its listening to merchandise earlier than it went public with a $141.3 million IPO final October.

Quite a few different firms supply direct-to-consumer listening to aids, together with Olive Union, which closed a $7 million Sequence B spherical earlier this 12 months, and Whisper, which scored $35 million in its personal Sequence B spherical final fall.

Audio equipment-maker Bose not too long ago made its approach into the house by releasing its FDA-cleared SoundControl listening to aids. The listening to aids have been developed for adults with perceived gentle to reasonable listening to loss and can be found direct-to-consumer with out a prescription.


Supply hyperlink

What's your reaction?

In Love
Not Sure

You may also like

More in:Health

Leave a reply

Your email address will not be published. Required fields are marked *